Drug intelligence / Profile preview

moronecidin-like peptide

Development stage
Preclinical
Modality
Peptides
Administration
In Vitro (not Yet Developed For Clinical Use)
01

Overview

**Moronecidin-like peptide** is a synthetic or naturally derived antimicrobial peptide belonging to the piscidin family, characterized by amphipathic α-helical structure and cationic properties[1][4]. It is found in various fish species, including Antarctic fishes (Notothenia coriiceps, Parachaenichthys charcoti) and is similar to moronecidin originally identified from the hybrid striped bass[2][4]. The peptide exhibits potent broad-spectrum **antibacterial** activity against both Gram-positive and Gram-negative bacteria as well as antifungal activity against *Candida albicans*, *Candida glabrata*, and *Candida tropicalis*[1][4]. The mechanism of action involves disruption of microbial cell membranes, leading to cell lysis, which is typical of antimicrobial peptides (AMPs)[1][4]. Its cytotoxicity and hemolytic activity on human cells are minimal, suggesting potential for therapeutic application against fungal infections, especially those caused by *Candida*[1][4]. Modification by C-terminal amidation increases the peptide's activity and can also increase toxicity; the non-amidated form generally exhibits lower cytotoxicity[1][2][4].

Other names
moronecidin-like antimicrobial peptidepiscidin-like peptide

Beyond the preview

Go deeper on moronecidin-like peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on moronecidin-like peptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call